Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

Am J Cardiol. 1999 Sep 1;84(5):598-600, A8. doi: 10.1016/s0002-9149(99)00387-2.

Abstract

This study examines the proportion of patients with ischemic heart disease who may be candidates for the newer modalities of revascularization. A significant proportion (approximately 5%) of patients who undergo coronary angiography at tertiary referral centers may be eligible for newer methods of therapy.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Coronary Angiography
  • Coronary Artery Bypass
  • Coronary Circulation / physiology*
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / physiopathology
  • Coronary Disease / surgery*
  • Endothelial Growth Factors / administration & dosage
  • Female
  • Humans
  • Lymphokines / administration & dosage
  • Male
  • Middle Aged
  • Neovascularization, Physiologic / drug effects
  • Neovascularization, Physiologic / physiology
  • Patient Selection*
  • Prognosis
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors